Intervention
Nelfinavir mesylate
ClinicalTrials.gov intervention label
Clinical trials
60 shownEffectiveness of Adding Interleukin-2 to Anti-HIV Drugs in Patients Recently Infected With HIVNCT00006441 · 2003-02-01
COMPLETEDCombination Treatment With and Without Protease Inhibitors for Women Who Begin Therapy for HIV Infection During PregnancyNCT00017719 · 2002-05-01
COMPLETEDA Comparison of Atazanavir and Nelfinavir, Each in Combination With 2 NRTIs, in Patients Who Have Failed Treatments Without a Protease InhibitorNCT00028067 · 2001-08-01
TERMINATEDDepo-Medroxyprogesterone Acetate (DMPA, Depo-Provera) Use With Certain Anti-HIV Drugs in HIV-Infected WomenNCT00016601 · 2001-06-01
COMPLETEDDrug Interactions of Amprenavir and Efavirenz, in Combination With a Second Protease Inhibitor, in HIV-Negative VolunteersNCT00005762 · 2001-03-01
COMPLETEDA Study to Determine How and Why HIV-Infected Subjects on Anti-viral Treatment Develop LipodystrophyNCT00006190 · 2000-11-01
COMPLETEDComparison of GW433908/Ritonavir to Nelfinavir When Used With Abacavir and Lamivudine in Patients That Have Not Taken Antiretroviral DrugsNCT00009061 · 2000-11-01
UNKNOWNComparison of GW433908 and Nelfinavir in HIV Patients Who Have Not Had Antiretroviral TherapyNCT00008554 · 2000-11-01
UNKNOWNA Study of Capravirine Plus VIRACEPT Plus Two Nucleoside Reverse Transcriptase Inhibitors in HIV-Infected Patients Who Failed Previous Anti-HIV TreatmentsNCT00006211 · 2000-02-01
COMPLETEDCombination Treatment Using Capravirine (AG1549), Nelfinavir, and Two Nucleoside Reverse Transcriptase Inhibitors in HIV Patients Who Failed Initial Combination TherapyNCT00004985 · 2000-01-01
COMPLETEDTreatment With Nelfinavir or Efavirenz of HIV-Infected Patients Who Have Never Received Anti-HIV DrugsNCT00005000 · 1999-12-01
UNKNOWNSafety and Effectiveness of a New Anti-HIV Drug (AG1549) in Combination With Other Anti-HIV Drugs in HIV-Infected PatientsNCT00004998 · 1999-11-01
SUSPENDEDA Comparison of Three Anti-HIV Drug Combinations in HIV-Infected PatientsNCT00005106 · 1999-09-01
COMPLETEDEffectiveness of a New Anti-HIV Drug (AG1549) Plus Viracept (Nelfinavir) Plus Combivir (Zidovudine/Lamivudine) in HIV-Infected PatientsNCT00004999 · 1999-08-01
SUSPENDEDEvaluation of an Anti-HIV Drug Combination That Includes a Coated Form of Didanosine (ddI EC) Compared to a Typical Anti-HIV Drug RegimenNCT00002429 · 1999-07-01
COMPLETEDA Study to Compare the Safety and Effectiveness of Two Dosing Schedules of Lamivudine in Combination With Two Other Anti-HIV DrugsNCT00002442 · 1999-06-01
COMPLETEDComparison of Two Anti-HIV Regimens That Include One of Two Forms of Didanosine (ddI)NCT00002224 · 1999-03-01
COMPLETEDA Study to Compare Two Anti-HIV Drug Combinations That Include Amprenavir in HIV-Infected Patients Who Have Failed Anti-HIV Drug Combinations That Did Not Include AmprenavirNCT00002423 · 1999-03-01
COMPLETEDStudy of a New Protease Inhibitor, BMS-232632, in Combination With Other Anti-HIV DrugsNCT00002240 · 1999-03-01
COMPLETEDA Phase III Study Comparing Two Different Anti-HIV Drug Combinations in HIV-Positive Patients Without Previous Anti-HIV Drug TherapyNCT00004583 · 1999-03-01
COMPLETEDA Comparison of Two Triple-Drug Combinations in Patients Who Have Never Been Treated With Anti-HIV DrugsNCT00002411 · 1998-03-01
COMPLETEDSafety, Tolerability, and Anti-HIV Activity of DMP 266 (Efavirenz) in Combination With Nelfinavir in HIV-Positive ChildrenNCT00000893 · 1997-10-01
COMPLETEDA Pilot Open Label Trial of HIV Therapy With d4T (Stavudine), ddI (Didanosine), Nelfinavir and Hydroxyurea in Subjects With Recent HIV InfectionNCT00002177 · 1997-05-01
COMPLETEDA Pilot Open Label Trial of HIV Therapy With d4T (Stavudine), ddI (Didanosine), Nelfinavir and Hydroxyurea in Subjects With Early Asymptomatic HIV InfectionNCT00002176 · 1997-05-01
COMPLETEDA Study of Saquinavir Soft Gel Capsules (SGC) Used in Combination With Two Other Anti-HIV Drugs in Patients With HIV-Associated Kidney DiseaseNCT00002397
COMPLETEDSafety and Effectiveness of Giving Indinavir and Nelfinavir to HIV-Infected PatientsNCT00002375
COMPLETEDA Study to Compare the Effectiveness of Two Anti-HIV Drug CombinationsNCT00002430
COMPLETEDA Study of 141W94 in Combination With Other Anti-HIV DrugsNCT00002372
COMPLETEDA Comparison of Two Multi-Drug Therapies in HIV-Infected Patients Who Have Never Received Anti-HIV TreatmentNCT00002216
COMPLETEDSafety and Effectiveness of Giving Combinations of Three or Four Anti-HIV Drugs to HIV-Infected PatientsNCT00002211
COMPLETEDA Study of Viracept in AIDS Patients With Cytomegalovirus RetinitisNCT00002169
COMPLETEDA Study of Viracept in AIDS Patients With Mycobacterium Avium Complex Disease (MAC)NCT00002170
COMPLETEDA Study of Ritonavir (ABT-538) When Used With Nelfinavir in HIV-Infected PatientsNCT00002201
COMPLETEDA Pilot, Open-Label, Phase II, Randomized Study to Determine the Effects of Viracept on the Outcome of Cutaneous and Mucosal KS in AIDS Patients With CD4 <= 500 Cells/mm3NCT00002185
COMPLETEDThe Safety and Effectiveness of Nevirapine Plus Nelfinavir in HIV-1 Infected Patients Who Have Taken StavudineNCT00002381
COMPLETEDA Study on the Safety and Effectiveness of Twice-Daily Nelfinavir Plus Twice-Daily Indinavir Plus Efavirenz in HIV-Positive Patients Who Have Never Taken Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs) or Protease InhibitorsNCT00002235
COMPLETEDViracept Expanded Access ProgramNCT00002165
COMPLETEDA Randomized, Double-Blind Study of MKC-442 Combined With Viracept in Patients Who Are Epivir + Retrovir Experienced and Are Protease Inhibitor- and Non-Nucleoside Reverse Transcriptase Inhibitor-NaiveNCT00002215
COMPLETEDA Comparison of Three Anti-HIV Drug Combinations Containing Saquinavir Soft Gelatin Capsules Used in HIV-1 Infected PatientsNCT00002378
COMPLETEDA Study of Viracept in HIV-Positive WomenNCT00002171
COMPLETEDA Study of Saquinavir Soft Gelatin Capsules Combined With Other Anti-HIV Drugs in HIV-1 Infected PatientsNCT00002374
COMPLETEDPhase I Study of Safety, Tolerability, and Pharmacokinetics of Viracept in HIV-1 Infected Children and Exposed InfantsNCT00002164
COMPLETEDA Phase IIIB Open-Label, Comparative Study to Evaluate Saquinavir Soft Gel Capsule (SGC) Treatment in Combination With Other Antiretrovirals in HIV-1 Infected Antiretroviral-Naive PatientsNCT00002178
COMPLETEDA Phase II, Stratified, Randomized, Double-Blind, Multi-Center Study of the Safety and Efficacy of Adefovir Dipivoxil (ADF) at Two Dose Levels in Triple Combination Therapies With Protease Inhibitors (PI) and Nucleoside Reverse Transcriptase Inhibitors (RTI) for the Treatment of HIV-Infected PatientNCT00002184
COMPLETEDA Study of 1592U89 in Combination With Protease Inhibitors in HIV-Infected Patients Who Have Never Taken Anti-HIV DrugsNCT00002440
COMPLETEDA Study on Possible Interactions Between Protease Inhibitors (Anti-HIV Drugs) and Drugs Which Lower the Level of Fat in Your BloodNCT00000941
COMPLETEDA Study of Several Anti-HIV Drug Combinations in HIV-Infected Patients Who Have Used IndinavirNCT00000892
COMPLETEDSafety and Effectiveness of Four Anti-HIV Drug Combinations in HIV-Infected Children and TeensNCT00001091
COMPLETEDA Study of the Safety and Effectiveness of Treating Advanced AIDS Patients Between Ages 4 and 22 With 7 Drugs, Some at Higher Than Usual DosesNCT00001108
COMPLETEDThe Effectiveness of Nelfinavir and Efavirenz, Used Alone or Together, Combined With Other Anti-HIV Drugs in Patients Who Have Taken Anti-HIV DrugsNCT00001087
COMPLETEDA Study on the Effect of Chemotherapy Combined With Anti-HIV Drugs in HIV-Positive PatientsNCT00000899
COMPLETEDA Study to Evaluate the Safety and Tolerance of Nelfinavir (NFV) Given With Zidovudine (ZDV) and Lamivudine (3TC) in HIV-Positive Pregnant Women and Their InfantsNCT00000887
COMPLETEDA Study on the Management of Combination Anti-HIV Drug Therapy in HIV-Positive Children With Prior TreatmentNCT00000902
COMPLETEDA Randomized Trial of the Efficacy and Safety of a Strategy of Starting With Nelfinavir Versus Ritonavir Added to Background Antiretroviral (AR) Nucleoside Therapy in HIV-Infected Individuals With CD4+ Cell Counts Less Than or Equal to 200/mm3NCT00000859
COMPLETEDA Study on Amprenavir in Combination With Other Anti-HIV Drugs in HIV-Positive PatientsNCT00000912
COMPLETEDA Study to Compare Two Anti-HIV Combination Therapies Each Containing Saquinavir in HIV-Positive ChildrenNCT00000913
COMPLETEDA Study to Compare Two Different Anti-HIV Drug RegimensNCT00000924
COMPLETEDA Study to Learn More About MAC Disease and the Use of Anti-HIV Drugs in Patients With Advanced HIV InfectionNCT00000895
COMPLETEDA Study of the Effectiveness of Different Anti-HIV Treatments in HIV-Positive Individuals Who Have Been on a Protease Inhibitor-Containing Drug Regimen for at Least 16 WeeksNCT00000914
COMPLETEDThe Effects of Staggered Dosing on Interactions Between Paired Combinations of Nelfinavir, Ritonavir, and SaquinavirNCT00000898
COMPLETEDCommon conditions
Leading sponsors
National Institute of Allergy and Infectious Diseases (NIAID)31Agouron Pharmaceuticals12Glaxo Wellcome8Bristol-Myers Squibb7Hoffmann-La Roche5Merck Sharp & Dohme LLC3Abbott2Gilead Sciences2Boehringer Ingelheim1National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)1Pharmacia and Upjohn1Triangle Pharmaceuticals1
Trial status mix
COMPLETED65
UNKNOWN5
SUSPENDED2
TERMINATED1
WITHDRAWN1
Phase mix
PHASE223
NA21
PHASE314
PHASE113
PHASE43
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.